These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8640778)

  • 1. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
    Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
    Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
    Younes M; Lechago LV; Lechago J
    Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of Glut3 in human tumors and normal tissues.
    Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
    Anticancer Res; 1997; 17(4A):2747-50. PubMed ID: 9252709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
    Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
    Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
    Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
    Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
    Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
    Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
    Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
    Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
    Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
    J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
    Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A
    Oncology; 2004; 66(5):404-10. PubMed ID: 15331928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of facilitative glucose transporters in gastric tumors.
    Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
    Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of the human erythrocyte glucose transport protein are determined by cellular context.
    Levine KB; Robichaud TK; Hamill S; Sultzman LA; Carruthers A
    Biochemistry; 2005 Apr; 44(15):5606-16. PubMed ID: 15823019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
    Visca P; Sebastiani V; Pizer ES; Botti C; De Carli P; Filippi S; Monaco S; Alo PL
    Anticancer Res; 2003; 23(1A):335-9. PubMed ID: 12680233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
    Cornford EM; Hyman S; Cornford ME; Landaw EM; Delgado-Escueta AV
    J Cereb Blood Flow Metab; 1998 Jan; 18(1):26-42. PubMed ID: 9428303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.
    Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M
    Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human erythrocyte sugar transport is incompatible with available carrier models.
    Cloherty EK; Heard KS; Carruthers A
    Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose transporter plasticity during memory processing.
    Choeiri C; Staines W; Miki T; Seino S; Messier C
    Neuroscience; 2005; 130(3):591-600. PubMed ID: 15590143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier.
    Busik JV; Olson LK; Grant MB; Henry DN
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2356-63. PubMed ID: 12091438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.